IQV

IQVIA Holdings

Healthcare Diagnostics & Research NYSE

About the company

IQVIA, the result of the 2016 merger between Quintiles and IMS Health, has emerged as a global leader in the healthcare industry. With its diverse portfolio of services, the company operates in two main segments: Research & Development and Technology & Analytics. The Research & Development segment is dedicated to providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. These trials play a crucial role in the development and approval of new treatments and medical advancements. IQVIA's expertise in managing and conducting clinical trials helps companies accelerate the process of bringing innovative products to market. In this segment, IQVIA offers a comprehensive range of services, including patient recruitment, site and investigator management, clinical monitoring, data management, statistical analysis, and regulatory support. Its global network of experienced professionals ensures that trials are conducted efficiently, adhering to the highest quality standards and regulatory requirements. On the other hand, the Technology & Analytics segment focuses on providing aggregated information and technology services to clients in the healthcare industry. IQVIA offers a wide array of solutions to pharmaceutical companies, providers, payers, policymakers, and other stakeholders. These services include data and analytics capabilities for clinical trials, real-world evidence analysis, market insights, and customer engagement strategies. One of the key areas of expertise within the Technology & Analytics segment is virtual trials. Virtual trials leverage digital technologies to conduct studies remotely, eliminating the need for traditional physical locations and reducing participant burden. IQVIA harnesses its vast network and technological capabilities to enable virtual trials, increasing access to patient populations and enhancing flexibility in the research process. Additionally, IQVIA supports the healthcare industry through its contract sales business, which provides expertise in pharmaceutical sales and marketing. This service helps companies optimize their commercial efforts, ensuring their products reach the right target audiences effectively. IQVIA's ability to merge its deep understanding of the healthcare landscape with advanced technology and analytics has positioned the company as a trusted partner for industry players. By leveraging its vast data resources and expertise, IQVIA empowers clients to make informed decisions, improve patient outcomes, and drive healthcare innovation. Overall, IQVIA's integrated approach to research, analytics, and technology has revolutionized the way the healthcare industry operates. Its capabilities span the entire drug development lifecycle, from early-stage research to real-world data analysis, closing the gap between scientific progress and patient care. As the company continues to evolve and expand its services, it remains at the forefront of transforming healthcare through knowledge and innovation.

Website: https://www.iqvia.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric IQV Sector median Vs. industry
P/E 23.21 20.10 ↑ Above average
EPS 8.05 USD -1.14 USD ↑ Above average
Dividend yield 0.00% 0.00%
Profit margin 8.33% 0.00% ↑ Above average
ROE 22.49% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is IQVIA Holdings?
IQVIA, the result of the 2016 merger between Quintiles and IMS Health, has emerged as a global leader in the healthcare industry. With its diverse portfolio of services, the company operates in two main segments: Research & Development and Technology & Analytics. The Research & Development segment is dedicated to providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. These trials play a crucial role in the development and approval of new treatments and medical advancements. IQVIA's expertise in managing and conducting clinical trials helps companies accelerate the process of bringing innovative products to market. In this segment, IQVIA offers a comprehensive range of services, including patient recruitment, site and investigator management, clinical monitoring, data management, statistical analysis, and regulatory support. Its global network of experienced professionals ensures that trials are conducted efficiently, adhering to the highest quality standards and regulatory requirements. On the other hand, the Technology & Analytics segment focuses on providing aggregated information and technology services to clients in the healthcare industry. IQVIA offers a wide array of solutions to pharmaceutical companies, providers, payers, policymakers, and other stakeholders. These services include data and analytics capabilities for clinical trials, real-world evidence analysis, market insights, and customer engagement strategies. One of the key areas of expertise within the Technology & Analytics segment is virtual trials. Virtual trials leverage digital technologies to conduct studies remotely, eliminating the need for traditional physical locations and reducing participant burden. IQVIA harnesses its vast network and technological capabilities to enable virtual trials, increasing access to patient populations and enhancing flexibility in the research process. Additionally, IQVIA supports the healthcare industry through its contract sales business, which provides expertise in pharmaceutical sales and marketing. This service helps companies optimize their commercial efforts, ensuring their products reach the right target audiences effectively. IQVIA's ability to merge its deep understanding of the healthcare landscape with advanced technology and analytics has positioned the company as a trusted partner for industry players. By leveraging its vast data resources and expertise, IQVIA empowers clients to make informed decisions, improve patient outcomes, and drive healthcare innovation. Overall, IQVIA's integrated approach to research, analytics, and technology has revolutionized the way the healthcare industry operates. Its capabilities span the entire drug development lifecycle, from early-stage research to real-world data analysis, closing the gap between scientific progress and patient care. As the company continues to evolve and expand its services, it remains at the forefront of transforming healthcare through knowledge and innovation.
Are IQVIA Holdings shares expensive?
The price-to-earnings (P/E) ratio of IQVIA Holdings is 23.21 — the share price is 23.21 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is IQVIA Holdings?
The market capitalization of IQVIA Holdings — the combined value of all its shares — is 31.18 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does IQVIA Holdings pay dividends?
The dividend yield of IQVIA Holdings is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does IQVIA Holdings belong to?
IQVIA Holdings operates in the Healthcare sector, industry: Diagnostics & Research.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120